NOV-205
NOV205-C201
Phase 2 small_molecule completed
Quick answer
NOV-205 for Hepatitis C is a Phase 2 program (small_molecule) at Cellectar Biosciences with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Cellectar Biosciences
- Indication
- Hepatitis C
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed